Fig. 1From: Innovative substance 2250 as a highly promising anti-neoplastic agent in malignant pancreatic carcinoma - in vitro and in vivoMolecular structure of substances TRLT and 2250. Substance 2250, 1.4.5-oxathiazan-dioxid-4.4, is an oxathiazine derivative like TRLT with a moleculare weight of 137.15Â g/molBack to article page